ALZAMEND NEURO INC: PLANS TO INITIATE PHASE II CLINICAL STUDY OF AL001 FOR TREATMENT OF PATIENTS WITH PTSD IN Q4 2025

Reuters · 03/11 12:14

Please log in to view news